Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
12/06/2020 | 22:53 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3/a) | NASDAQ:APLT | Applied Therapeutics Inc |
10/06/2020 | 12:03 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:APLT | Applied Therapeutics Inc |
08/06/2020 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Present Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at 2020 American Diabetes Associa... | NASDAQ:APLT | Applied Therapeutics Inc |
06/06/2020 | 00:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:APLT | Applied Therapeutics Inc |
05/06/2020 | 22:49 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APLT | Applied Therapeutics Inc |
05/06/2020 | 12:03 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:APLT | Applied Therapeutics Inc |
05/06/2020 | 12:01 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:APLT | Applied Therapeutics Inc |
03/06/2020 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference | NASDAQ:APLT | Applied Therapeutics Inc |
01/06/2020 | 23:07 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:APLT | Applied Therapeutics Inc |
27/05/2020 | 00:44 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:APLT | Applied Therapeutics Inc |
26/05/2020 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Busi... | NASDAQ:APLT | Applied Therapeutics Inc |
12/05/2020 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Present at the UBS Global Healthcare Conference | NASDAQ:APLT | Applied Therapeutics Inc |
11/05/2020 | 13:49 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:APLT | Applied Therapeutics Inc |
11/05/2020 | 13:36 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:APLT | Applied Therapeutics Inc |
11/05/2020 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Reports First Quarter 2020 Financial Results | NASDAQ:APLT | Applied Therapeutics Inc |
23/04/2020 | 15:08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:APLT | Applied Therapeutics Inc |
23/04/2020 | 15:06 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:APLT | Applied Therapeutics Inc |
21/04/2020 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia Trial | NASDAQ:APLT | Applied Therapeutics Inc |
02/04/2020 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Announces IND and Investigator-Initiated Studies of AT-001 in Critical COVID-19 Patients | NASDAQ:APLT | Applied Therapeutics Inc |
13/03/2020 | 15:11 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:APLT | Applied Therapeutics Inc |
13/03/2020 | 12:00 | GlobeNewswire Inc. | Applied Therapeutics Reports Fourth Quarter and Year-end 2019 Financial Results | NASDAQ:APLT | Applied Therapeutics Inc |
10/03/2020 | 12:00 | GlobeNewswire Inc. | Applied Therapeutics to Present at the Barclays Global Healthcare Conference | NASDAQ:APLT | Applied Therapeutics Inc |
03/03/2020 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Appoints Adam Hansard as Chief Commercial Officer | NASDAQ:APLT | Applied Therapeutics Inc |
26/02/2020 | 22:05 | GlobeNewswire Inc. | Applied Therapeutics to Present at the Cowen and Company 40th Annual Health Care Conference | NASDAQ:APLT | Applied Therapeutics Inc |
15/02/2020 | 07:02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:APLT | Applied Therapeutics Inc |
14/02/2020 | 23:40 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:APLT | Applied Therapeutics Inc |
14/02/2020 | 14:16 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:APLT | Applied Therapeutics Inc |
28/01/2020 | 18:24 | GlobeNewswire Inc. | Applied Therapeutics, Inc. Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchas... | NASDAQ:APLT | Applied Therapeutics Inc |
24/01/2020 | 03:28 | GlobeNewswire Inc. | Applied Therapeutics, Inc. Announces Upsizing and Pricing of Public Offering of 2,741,489 Shares of Common Stock | NASDAQ:APLT | Applied Therapeutics Inc |
21/01/2020 | 22:16 | GlobeNewswire Inc. | Applied Therapeutics, Inc. Announces Offering of 1,750,000 Shares of Common Stock | NASDAQ:APLT | Applied Therapeutics Inc |